Clinical Trials Browser

Recruiting × Breast Neoplasms × Androgen Antagonists × Clear all

NCT07340541 2026-04-13

EVOLVE-BDT

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms